HighVista Strategies LLC

Position in OCUL — Ocular Therapeutix, Inc

CIK 1335325 BOSTON, MA

Position in OCUL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,011,803

+$271,680 QoQ

Shares Held

408,534

-7.5% QoQ

Ownership

0.186%

of shares outstanding

% of Portfolio

0.92%

of 13F equity value

Holder Rank

#56

of 257 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighVista Strategies LLC holds $278,365,756 across 70 Biotechnology names. OCUL ranks #29 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,031	$15,062,511
2	RVMD	Revolution Medicines, Inc.	66,983	$12,544,576
3	DFTX	Definium Therapeutics, Inc.	242,884	$11,425,263
4	IMVT	Immunovant, Inc.	277,873	$10,706,446
5	PRAX	Praxis Precision Medicines, Inc.	30,210	$10,114,005
6	RLAY	Relay Therapeutics, Inc.	506,235	$9,471,656
7	PCVX	Vaxcyte, Inc.	149,739	$8,704,328
8	TNGX	Tango Therapeutics, Inc.	260,070	$8,129,788

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,011,803	408,534	-7.5%	Shares	Sole	2026-08-14
2026-03-31	$3,740,123	441,573	+28.3%	Shares	Sole	2026-05-15
2025-12-31	$4,176,973	344,067	+222.7%	Shares	Sole	2026-02-17
2025-09-30	$1,246,282	106,611	+20.0%	Shares	Sole	2025-11-14
2025-06-30	$824,769	88,876	+4.3%	Shares	Sole	2025-08-14
2025-03-31	$624,816	85,241	0.0%	Shares	Sole	2025-05-15
2024-12-31	$727,958	85,241	+31.1%	Shares	Sole	2025-02-14
2024-09-30	$565,734	65,027	+5.1%	Shares	Sole	2024-11-14
2024-06-30	$423,115	61,859	+4.9%	Shares	Sole	2024-08-14
2021-12-31	$410,986	58,965	-14.6%	Shares	Sole	2022-02-14
2021-09-30	$690,620	69,062	+12.0%	Shares	Sole	2021-11-15
2021-06-30	$874,041	61,639	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.